动物实验,抗疟疾疫苗 z-bo 2020-09-08 366

　　A team led by researchers at Imperial College London found that, based on animal studies, combining two different anti-malaria vaccines is better than using two vaccines alone. Malaria is a disease caused by Plasmodium, which is spread by mosquito bites. Symptoms include fever, headache and vomiting. If left untreated, it may be life-threatening.

　　The research team tested two malaria vaccines, TBV and PEV, in an experiment. Both are still in different stages of clinical trials. In this experiment, the research team used mice and genetically engineered parasites that have certain characteristics with the malaria parasite.

　　The research team reported in the American "Electronic Life" magazine that animal experiments showed that the two vaccines alone can reduce the risk of malaria by 48% and 68%, respectively. If you use the two together, you may get infected. The risk is reduced by 91%. Imperial University scholar Andrew Braggborough, one of the authors of the report, said that achieving this effect will have a positive impact on public health, especially in areas where malaria is more common. Next, researchers will study the effects of combining different vaccines in a more complex environment.